Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Follica Inc.

Gelesis's Obesity Product FDA Acceptance Gives Boost To PureTech's Portfolio

Approvals Metabolic Disorders

IP Commercializer PureTech's CEO Outlines 2018 Roadmap After Financing

Daphne Zohar tells Scrip PureTech will use $100m placing to develop Boston-based group's growth-stage affiliates and advance its "BIG" proprietary pipeline of brain-immune-gut assets.

Business Strategies Analysis

The A-List: 2010's Trend-Shaping Series A Financings

Investments for start-ups seeking their first infusion of venture capital continues to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising new funds.

Recent Financings of Private Companies (07/10)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
UsernamePublicRestriction

Register